Statin use may improve clinicopathological characteristics and recurrence risk of invasive breast cancer

Med Oncol. 2014 Feb;31(2):835. doi: 10.1007/s12032-013-0835-x. Epub 2014 Jan 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology
  • Carcinoma, Ductal, Breast / drug therapy*
  • Carcinoma, Ductal, Breast / mortality
  • Carcinoma, Ductal, Breast / pathology
  • Carcinoma, Lobular / drug therapy*
  • Carcinoma, Lobular / mortality
  • Carcinoma, Lobular / pathology
  • Female
  • Follow-Up Studies
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / etiology
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Staging
  • Prognosis
  • ROC Curve
  • Retrospective Studies
  • Risk Factors
  • Survival Rate

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors